#124209
Re: Farmas USA
Amarin loses appeals court ruling on Vascepa
1 minute ago, 3:36 p. m. CEST
By Stephen Alpher via
Seeking Alpha
Stocks mentioned: AMRN
Listen
Share
Save
Amarin's (NASDAQ:AMRN) bid to revive patents on heart treatment Vascepa has failed, with a U.S. Court of Appeals - just one day after hearing arguments - has affirmed the previous trial court ruling.
Jefferies says the Rule 36 judgement makes the odds about zero that the ruling can be appealed for en banc review or to the Supreme Court.
AMRN shares fell 30% yesterday as the hearing took place. They're up 1.8% in early action this morning.
Apelación pérdida.
Por eso la suspenden, no?